Skip to main navigation Skip to search Skip to main content

Revisiting Antiangiogenic Multikinase Inhibitors in the Era of Immune Checkpoint Blockade: The Case of Sorafenib

Dan G. Duda, Rakesh K. Jain

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Revisiting Antiangiogenic Multikinase Inhibitors in the Era of Immune Checkpoint Blockade: The Case of Sorafenib'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry